Close Menu

NEW YORK (GenomeWeb) – Agilent Technologies reported after the close of the market on Monday that its second quarter revenues rose 9 percent year over year, thanks to growth across all of its business units.

For the three months ended April 30, the life sciences company said total revenues rose to $1.21 billion from $1.10 billion in Q2 2017, in line with analysts' average estimate.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times Magazine examines gender discrimination at the Salk Institute.

Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.

A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.

In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.